Latest Breaking News On - Prnewswire moleculight inc - Page 1 : vimarsana.com

MolecuLight Inc.: MolecuLight's Pioneering Fluorescence Imaging Technology Showcased in Prestigious Burns Journal in Novel Study

TORONTO, May 30, 2024 /PRNewswire/ MolecuLight Inc., the global leader in fluorescence imaging technology for real-time detection of harmful bacteria in wound care, celebrates the publication

MolecuLight Inc.: MolecuLight's Innovative Approach Awarded Best Abstract at EWMA 2024

MolecuLight Successfully Completes SOC 2 Type II Audit

/PRNewswire/ MolecuLight Inc., the leader in point-of-care fluorescence imaging that locates and detects elevated bacterial loads in and around wounds,.

MolecuLight Inc.: MolecuLight Successfully Completes SOC 2 Type II Audit

MolecuLight Inc.: 12 Posters and Presentations Featuring MolecuLight to be Presented at the SAWC Fall 2023 Conference

Latest Clinical Evidence Presented at APWCA's Wound Week™ 2023 Illustrates the Significant and New Clinical Utility of the MolecuLight Point-of-Care Imaging Platform

/PRNewswire/ MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads,.

MolecuLight Inc.: Latest Clinical Evidence Presented at APWCA's Wound Week 2023 Illustrates the Significant and New Clinical Utility of the MolecuLight Point-of-Care Imaging Platform

Seasoned Healthcare Executive David Bassin Joins the MolecuLight Board of Directors

/PRNewswire/ MolecuLight Inc., the leader in point-of-care fluorescence imaging that locates and detects elevated, pathogenic bacterial loads in and around.

MolecuLight Featured in Unprecedented 24 Presentations and Posters at European Wound Management Association (EWMA) 2023 Annual Conference

/PRNewswire/ MolecuLight Inc., the leader in point-of-care fluorescence imaging that detects and locates elevated bacterial loads in wounds, announces that.

MolecuLight Inc.: MolecuLight Featured in Unprecedented 24 Presentations and Posters at European Wound Management Association (EWMA) 2023 Annual Conference

Wide-Spread Clinical Evidence using the MolecuLight Imaging Platform Reveals its Significant Global Adoption and Proven Utility in Wound Care TORONTO and MILAN, May 3, 2023 /PRNewswire/